Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community‐based organizations

Author:

Bowen Alexandra1,Gómez‐Trillos Sara23,Curran Geoffrey4,Graves Kristi D.23,Sheppard Vanessa B.5,Schwartz Marc D.23,Peshkin Beth N.23,Campos Claudia6,Garcés Nathaly2,Dash Chiranjeev2,Aburto Luisa7,Valencia‐Rojas Nancy5,Hernández Gina8,Villa Antonio58,Cupertino Paula9,Carrera Pilar10,Hurtado‐de‐Mendoza Alejandra23ORCID

Affiliation:

1. Rutgers University New Brunswick New Jersey USA

2. Georgetown University Medical Center Washington District of Columbia USA

3. Jess and Mildred Fisher Center for Hereditary Cancer and Clinical Cancer Genomics Research Washington District of Columbia USA

4. University of Arkansas for Medical Sciences Little Rock Arkansas USA

5. Virginia Commonwealth University Richmond Virginia USA

6. Nueva Vida Alexandria Virginia USA

7. Arlington Free Clinic Arlington Virginia USA

8. La Casa de la Salud Richmond Virginia USA

9. University of Rochester Medical Center Rochester New York USA

10. Universidad Autónoma de Madrid Madrid Spain

Abstract

AbstractGenetic counseling and testing (GCT) inform cancer management for persons at risk for hereditary breast and ovarian cancer (HBOC). Community‐based organizations (CBOs) may play a role in identifying at‐risk Latinx individuals to connect them to GCT but data are lacking. Two academic centers and their four CBO partners planned to implement a validated questionnaire for HBOC risk screening (“HBOC risk screening tool”). This study aimed to assess CBO's preferences for HBOC risk screening tools, as well as the barriers and facilitators anticipated for future implementation. Pre‐implementation focus groups were conducted with CBO's staff. Discussions centered on current practices to identify and refer at‐risk patients. During the discussion, staff were asked to select one out of five validated HBOC risk screening tools to implement and to discuss anticipated barriers/facilitators for implementation. The four focus groups were coded and qualitative analyzed following the Consolidated Framework for Implementation Research (CFIR) and Health Equity domains. All CBOs chose the Family History Screen 7 (FHS‐7). Participants (N = 35) highlighted how the FHS‐7 was easy to adapt to better fit the target population and changing guidelines. They had positive attitudes toward implementing the screening tool, stressed how the culture of the organization positioned them to reach the target population, and noted barriers in different CFIR domains (e.g., low knowledge about HBOC and GCT referrals; scarce available resources). Participants pointed to barriers related to health equity domains including limited access to GCT and follow‐up care for uninsured and underinsured populations, challenges obtaining accurate family history, and immigration‐related barriers. CBOs highlighted the importance of partnering with other stakeholders to overcome barriers. Findings emphasize the need to develop multi‐level implementation strategies to overcome barriers and leverage facilitators. This study can inform the development of implementation toolkits for CBOs to implement HBOC screening tools to advance health equity.

Funder

National Cancer Institute

Publisher

Wiley

Subject

Genetics (clinical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3